Aphexda 62 mg lyophilized powder for injection Images
Generic Name: motixafortide
This medication has been identified as Aphexda 62 mg lyophilized powder for injection. It is supplied by BioLineRx Ltd.
Aphexda is used in the treatment of Multiple Myeloma; Hematopoietic Stem Cell Mobilization and belongs to the drug class hematopoietic stem cell mobilizer. Aphexda 62 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Aphexda
- Generic Name
- motixafortide
- Strength
- 62 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Hematopoietic stem cell mobilizer
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- BioLineRx Ltd.
- National Drug Code (NDC)
- 82737-0073
More about Aphexda (motixafortide)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: hematopoietic stem cell mobilizer
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.